lufepirsen low dose

Drug identity checked against registry records

Also recorded as NEXAGON®

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDNCT05966493Glaukos CorporationPhase 2Recruiting2025-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.